2025
SJR Q3
JCR Q3 · 1,8
OA
25 matched articles
SCIE
Journal detail
Folia Biologica (Czech Republic)
- Publisher
- Charles University in Prague
- Country
- Czech Republic · Eastern Europe
- Type
- journal
- ISSN
-
0015550025337602
Integrated evaluation
Scopus side is Scimago SJR; WoS side is Master Journal List + JCR/JIF. Sources are matched on ISSN. WoS / JCR metrics are available for 1997 and later years only.
WoS / JCR data covers 1997 onward.
Scopus
Scopus · Scimago
- SJR 0,477
- Quartile Q3
- H-Index 39
- Cites/doc 1,67
- Docs (3y) 68
- Cites (3y) 122
Clarivate
Web of Science · JCR · 2025
- JCR Q Q3
- JIF 1,8
- 5Y JIF 1,3
- JCI 0,26
WoS indexes
- SCIE
Subject classification
Categories (SJR)
- Biochemistry Q3
- Cell Biology Q4
- Developmental Biology Q3
- Genetics Q3
- Immunology Q3
- Medicine (miscellaneous) Q3
- Molecular Biology Q4
Areas
- Biochemistry, Genetics and Molecular Biology
- Immunology and Microbiology
- Medicine
WoS categories
- Biology | Oncology
Yearly quartile comparison
Scimago (SJR) for all years; Clarivate (JCR / JIF / JCI) from 1997 onward. Latest year stays open; older years start collapsed.
WoS / JCR data covers 1997 onward.
| Year | SJR Q | JCR Q (1997+) | SJR | JIF (1997+) | 5Y JIF (1997+) | JCI (1997+) | JCI Q (1997+) | H-Index |
|---|---|---|---|---|---|---|---|---|
| 2025 | Q3 | Q3 | 0,477 | 1,8 | 1,3 | 0,26 | Q3 | 39 |
| 2024 | Q4 | Q4 | 0,229 | 0,6 | 0,9 | 0,14 | Q4 | 38 |
| 2023 | Q3 | Q3 | 0,265 | 1,1 | 1,2 | 0,18 | Q4 | 38 |
| 2022 | Q3 | Q4 | 0,294 | 0,6 | 1 | 0,16 | Q4 | 38 |
| 2021 | Q3 | Q4 | 0,288 | 1,2 | 1,2 | 0,17 | Q4 | 38 |
| 2020 | Q3 | Q4 | 0,325 | 0,9 | 1,1 | 0,16 | Q4 | 38 |
| 2019 | Q3 | Q4 | 0,324 | 0,7 | 0,9 | 0,19 | Q4 | 38 |
| 2018 | — | Q3 | — | 1,1 | 1 | 0,23 | Q3 | — |
| 2017 | Q3 | Q3 | 0,416 | 1 | 1,2 | 0,25 | Q3 | 38 |
| 2016 | Q2 | Q3 | 0,46 | 0,9 | 1 | — | — | 38 |
| 2015 | Q3 | Q3 | 0,39 | 0,8 | 1,1 | — | — | 38 |
| 2014 | Q3 | Q3 | 0,357 | 1 | 1,1 | — | — | 38 |
| 2013 | Q3 | Q3 | 0,357 | 1,2 | 1,1 | — | — | 38 |
| 2012 | Q2 | Q3 | 0,431 | 1,2 | 1,3 | — | — | 38 |
| 2011 | Q2 | Q3 | 0,366 | 1,2 | 1,2 | — | — | 38 |
| 2010 | Q3 | Q3 | 0,325 | 0,7 | 1 | — | — | 38 |
| 2009 | — | Q3 | — | 0,9 | 1,2 | — | — | — |
| 2008 | — | Q3 | — | 1,1 | 1,1 | — | — | — |
| 2007 | — | Q3 | — | 0,6 | 0,6 | — | — | — |
| 2006 | — | Q4 | — | 0,4 | — | — | — | — |
| 2005 | — | Q3 | — | 0,7 | — | — | — | — |
| 2004 | — | Q4 | — | 0,5 | — | — | — | — |
| 2003 | — | Q4 | — | 0,5 | — | — | — | — |
| 2002 | — | Q4 | — | 0,6 | — | — | — | — |
| 2001 | — | Q3 | — | 0,5 | — | — | — | — |
| 2000 | — | Q4 | — | 0,4 | — | — | — | — |
| 1999 | — | Q3 | — | 0,5 | — | — | — | — |
| 1998 | — | Q3 | — | 0,6 | — | — | — | — |
| 1997 | — | Q3 | — | 0,5 | — | — | — | — |
JCR category quartile history
JCR / JCI quartile by year and category. 1997 and later.
WoS / JCR data covers 1997 onward.
| Year | Category | Edition | JCR Q (1997+) | JCI Q (1997+) | Rank |
|---|---|---|---|---|---|
| 2025 | BIOLOGY | SCIE | Q3 | Q3 | 55/106 |
| 2025 | ONCOLOGY | SCIE | Q4 | Q4 | 264/333 |
| 2024 | BIOLOGY | SCIE | Q4 | Q4 | 85/107 |
| 2024 | ONCOLOGY | SCIE | Q4 | Q4 | 306/328 |
| 2023 | BIOLOGY | SCIE | Q3 | Q4 | 72/109 |
| 2023 | ONCOLOGY | SCIE | Q4 | Q4 | 281/322 |
| 2022 | BIOLOGY | SCIE | Q4 | Q4 | 83/92 |
| 2022 | ONCOLOGY | SCIE | Q4 | Q4 | 237/241 |
| 2021 | BIOLOGY | SCIE | Q4 | Q4 | 77/94 |
| 2021 | ONCOLOGY | SCIE | Q4 | Q4 | 239/245 |
| 2020 | BIOLOGY | SCIE | Q4 | Q4 | 79/93 |
| 2020 | ONCOLOGY | SCIE | Q4 | Q4 | 237/242 |
| 2019 | BIOLOGY | SCIE | Q4 | Q4 | 80/93 |
| 2019 | ONCOLOGY | SCIE | Q4 | Q4 | 238/244 |
| 2018 | BIOLOGY | SCIE | Q3 | Q3 | 61/87 |
| 2018 | ONCOLOGY | SCIE | Q4 | Q4 | 219/230 |
| 2017 | BIOLOGY | SCIE | Q3 | Q3 | 61/85 |
| 2017 | ONCOLOGY | SCIE | Q4 | Q4 | 214/223 |
| 2016 | BIOLOGY | SCIE | Q3 | — | 62/85 |
| 2016 | ONCOLOGY | SCIE | Q4 | — | 207/217 |
| 2015 | BIOLOGY | SCIE | Q3 | — | 63/86 |
| 2015 | ONCOLOGY | SCIE | Q4 | — | 203/213 |
| 2014 | BIOLOGY | SCIE | Q3 | — | 57/85 |
| 2014 | ONCOLOGY | SCIE | Q4 | — | 190/211 |
| 2013 | BIOLOGY | SCIE | Q3 | — | 51/85 |
| 2013 | ONCOLOGY | SCIE | Q4 | — | 174/203 |
| 2012 | BIOLOGY | SCIE | Q3 | — | 49/83 |
| 2012 | ONCOLOGY | SCIE | Q4 | — | 167/197 |
| 2011 | BIOLOGY | SCIE | Q3 | — | 51/85 |
| 2011 | ONCOLOGY | SCIE | Q4 | — | 160/196 |
| 2010 | BIOLOGY | SCIE | Q3 | — | 62/86 |
| 2010 | ONCOLOGY | SCIE | Q4 | — | 166/185 |
| 2009 | BIOLOGY | SCIE | Q3 | — | 50/76 |
| 2009 | ONCOLOGY | SCIE | Q4 | — | 145/166 |
| 2008 | BIOLOGY | SCIE | Q3 | — | 45/72 |
| 2008 | ONCOLOGY | SCIE | Q4 | — | 131/143 |
| 2007 | BIOLOGY | SCIE | Q3 | — | 52/71 |
| 2007 | ONCOLOGY | SCIE | Q4 | — | 129/132 |
| 2006 | BIOLOGY | SCIE | Q4 | — | 52/65 |
| 2006 | ONCOLOGY | SCIE | Q4 | — | 125/127 |
| 2005 | BIOLOGY | SCIE | Q3 | — | 47/65 |
| 2005 | CELL BIOLOGY | SCIE | Q4 | — | 140/153 |
| 2005 | IMMUNOLOGY | SCIE | Q4 | — | 107/115 |
| 2004 | CELL BIOLOGY | SCIE | Q4 | — | 144/155 |
| 2004 | IMMUNOLOGY | SCIE | Q4 | — | 107/111 |
| 2003 | CELL BIOLOGY | SCIE | Q4 | — | 143/156 |
| 2003 | IMMUNOLOGY | SCIE | Q4 | — | 106/114 |
| 2002 | CELL BIOLOGY | SCIE | Q4 | — | 139/153 |
| 2002 | IMMUNOLOGY | SCIE | Q4 | — | 106/119 |
| 2001 | BIOLOGY | SCIE | Q3 | — | 31/42 |
| 2000 | BIOLOGY | SCIE | Q4 | — | 41/51 |
| 1999 | BIOLOGY | SCIE | Q3 | — | 37/53 |
| 1998 | BIOLOGY | SCIE | Q3 | — | 40/66 |
| 1997 | BIOLOGY | SCIE | Q3 | — | 41/63 |